A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer

Clinical trial NCT02333890 · UNKNOWN

Trial details

NCT number: NCT02333890
Sponsor: Ottawa Hospital Research Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Invasive Breast Cancer

Start date: 2015-07-01
Primary completion: 2017-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.